The medical data provider has now secured almost $78m in total, with Novartis and Qualcomm venture DRx Capital returning for its series B round.
US-based healthcare data platform developer H1 completed a $58m series B round yesterday that included DRx Capital, the joint investment venture formed by pharmaceutical firm Novartis and mobile chipmaker Qualcomm.
Venture capital firms IVP and Menlo Ventures co-led the round, which also featured Transformation Capital, Lux Capital, Lead Edge Capital and YC Combinator.
H1’s cloud-based data repository covering some 16,000 healthcare organisations, 700 medical societies, 350,000 clinical trials and 160 million peer-review publications, utilising data science technology to provide insight…
